Quentis Therapeutics Alternatives & Competitors
12 companies similar to Quentis Therapeutics — Developing innovative immuno-therapeutics to combat ER stress and empower the im...
Companies similar to Quentis Therapeutics
Trillium Therapeutics Inc.
Clinical stage immuno-oncology company developing innovative therapies for the treatment o...
GLIKNIK INC.
Harnessing innovation to empower immune responses and combat cancer with advanced peptide,...
Boostimmune
Developing breakthrough therapies to fight cancer by harnessing the power of the immune sy...
IRX Therapeutics
Developing immune therapies to activate the body's natural defense against cancer and rela...
Rival Readout
Competing with Quentis Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
NeoPhore Ltd
Discovering drugs that create neoantigens
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
Oncofactor Corporation
A Seattle-based innovator in cancer treatments, disrupting tumor-immune system signaling p...
ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...
Werewolf Therapeutics
Advancing a pipeline of next generation, transformative immuno-stimulatory medicines for c...
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Creative BioTherapeutics LLC
An emerging biotech discovering & developing novel therapies for cancer and viruses where...
About Quentis Therapeutics
Quentis Therapeutics is a biotechnology startup founded in 2016 that is focused on developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer. The company's slogan, "Developing innovative immuno-therapeutics to combat ER stress and empower the immune system i...
Immuno-therapeutics, ER Stress, Cancer Treatment, Immune System, Cancer Therapy, Innovative Treatments, Biopharmaceuticals, Oncology, Drug Development, Immunotherapy, Cancer Research
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Quentis Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Quentis Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.